Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fifteen research firms that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]
Banc of California, Inc. (NYSE:BANC – Free Report) – Stock analysts at Wedbush reduced their FY2025 earnings per share estimates for shares of Banc of California in a research report issued on Monday, May 13th. Wedbush analyst D. Chiaverini now forecasts that the bank will earn $1.90 per share for the year, down from their […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective lowered by Morgan Stanley from $10.00 to $4.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. A number of other analysts have also recently weighed in on […]
Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $2.00 at Barclays tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California (PACB) Set to Announce Earnings on Thursday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.